Yi Y - Search Results

1

miR-574-5p mediates epithelial-mesenchymal transition in small cell lung cancer by targeting vimentin via a competitive endogenous RNA network.

Sun Y, Yi Y, Gan S, Ye R, Huang C, Li M, Huang J, Guo Y. Sun Y, et al. Among authors: yi y. Oncol Lett. 2021 Jun;21(6):459. doi: 10.3892/ol.2021.12720. Epub 2021 Apr 8. Oncol Lett. 2021. PMID: 33907569 Free PMC article.

2

The EMT-related transcription factor snail up-regulates FAPα in malignant melanoma cells.

Yi Y, Wang Z, Sun Y, Chen J, Zhang B, Wu M, Li T, Hu L, Zeng J. Yi Y, et al. Exp Cell Res. 2018 Mar 15;364(2):160-167. doi: 10.1016/j.yexcr.2018.01.039. Epub 2018 Feb 2. Exp Cell Res. 2018. PMID: 29410133

3

Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs.

Wu M, Sun Y, Xu F, Liang Y, Liu H, Yi Y. Wu M, et al. Among authors: yi y. J Cancer. 2019 Jan 29;10(5):1077-1085. doi: 10.7150/jca.29440. eCollection 2019. J Cancer. 2019. PMID: 30854114 Free PMC article.

4

Cip2a induces arginine biosynthesis and promotes tumor progression in non-small cell lung cancer.

Chen D, Fan S, Wang J, Liang Y, Li P, Lv X, Sun Y, Wang Q, Liu H, Zhang C, Yi Y. Chen D, et al. Among authors: yi y. Mol Carcinog. 2023 Apr;62(4):561-572. doi: 10.1002/mc.23507. Epub 2023 Jan 27. Mol Carcinog. 2023. PMID: 36705466

5

Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.

Yi Y, Zeng S, Wang Z, Wu M, Ma Y, Ye X, Zhang B, Liu H. Yi Y, et al. Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):793-803. doi: 10.1016/j.bbadis.2017.12.021. Epub 2017 Dec 16. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29253515 Free article.

6

Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149.

He Y, Chen D, Yi Y, Zeng S, Liu S, Li P, Xie H, Yu P, Jiang G, Liu H. He Y, et al. Among authors: yi y. Mol Ther Oncolytics. 2020 May 8;17:448-459. doi: 10.1016/j.omto.2020.05.001. eCollection 2020 Jun 26. Mol Ther Oncolytics. 2020. PMID: 32478168 Free PMC article.

7

MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2.

Wu M, Ye X, Wang S, Li Q, Lai Y, Yi Y. Wu M, et al. Among authors: yi y. Onco Targets Ther. 2017 Jun 2;10:2815-2822. doi: 10.2147/OTT.S135664. eCollection 2017. Onco Targets Ther. 2017. PMID: 28652762 Free PMC article.

8

P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer.

Yi Y, Li P, Huang Y, Chen D, Fan S, Wang J, Yang M, Zeng S, Deng J, Lv X, Luo K, He Z, Liu H. Yi Y, et al. Oncogene. 2022 Sep;41(37):4318-4329. doi: 10.1038/s41388-022-02438-z. Epub 2022 Aug 19. Oncogene. 2022. PMID: 35986102

9

METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells.

Fan S, Lv X, Zhang C, Zeng B, Liang Y, Chen D, Xu Z, Li P, Wu S, Liu H, Luo K, Liu Z, Yi Y. Fan S, et al. Among authors: yi y. Mol Cancer Res. 2024 Nov 1;22(11):1051-1063. doi: 10.1158/1541-7786.MCR-23-1018. Mol Cancer Res. 2024. PMID: 38953880

10

β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells.

Zhang F, Li P, Liu S, Yang M, Zeng S, Deng J, Chen D, Yi Y, Liu H. Zhang F, et al. Among authors: yi y. Oncogene. 2021 Sep;40(39):5854-5865. doi: 10.1038/s41388-021-01986-0. Epub 2021 Aug 3. Oncogene. 2021. PMID: 34345015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,754 results

Search Page

Filters